Latest News and Press Releases
Want to stay updated on the latest news?
-
MORRISTOWN, N.J., Sept. 9, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman, President and...
-
MORRISTOWN, N.J., Aug. 24, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or "the Company"), a specialty pharmaceutical company, today announced the completion of a...
-
Revenues Increase Over 150% Year-Over-Year Company Provides Updated Financial Guidance MORRISTOWN, N.J., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX)...
-
MORRISTOWN, N.J., July 27, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced positive results from Category 1 (in...
-
Pernix Therapeutics Inc. to Report Second Quarter 2015 Financial Results on Thursday, August 6, 2015
MORRISTOWN, N.J., July 24, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that it will release its 2015 second quarter...
-
MORRISTOWN, N.J., June 15, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (Nasdaq:PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman, President and...